Last quarter (Q3 2023), Theravance Biopharma's total revenue was $15.69M, an increase of 26.04% from the same quarter last year. In Q3, Theravance Biopharma's net income was $-8.95M. See Theravance Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 54.50M	$ 51.35M	$ 55.31M	$ 71.86M	$ 73.41M	$ 60.37M
Cost of Revenue	-	-	-	$ 0.00	$ 0.00	$ 715.00K
Gross Profit	$ 54.51M	$ 51.35M	$ 55.31M	$ 71.86M	$ 73.41M	$ 59.66M
Operating Expense	$ 62.63M	$ 143.30M	$ -313.10M	$ 369.61M	$ 325.33M	$ 298.41M
Operating Income	$ -73.16M	$ -91.96M	$ -299.70M	$ -297.76M	$ -251.91M	$ -238.75M
Net Non Operating Interest Income Expense	$ 16.99M	$ -6.37M	$ -8.55M	$ -40.14M	$ -23.47M	$ 1.48M
Other Income Expense	$ 42.25M	$ -5.51M	$ -1.11M	$ 51.36M	$ 33.70M	$ 11.18M
Pretax Income	$ -87.43M	$ -92.81M	$ -265.22M	$ -286.54M	$ -241.68M	$ -226.09M
Tax Provision	$ 1.92M	$ 9.00K	$ -151.00K	$ -8.52M	$ -5.22M	$ -10.56M
Earnings From Equity Interest Net Of Tax	$ -53.24M	-	$ 103.99M	-	-	-
Net Income Common Stockholders	$ -77.68M	$ 832.40M	$ -261.49M	$ -278.02M	$ -236.46M	$ -215.52M
Basic EPS	$ -1.09	$ 23.70	$ -2.87	$ -4.46	$ -4.25	$ -3.99
Diluted EPS	$ -0.78	$ 23.70	$ -2.87	$ -4.46	$ -4.25	$ -3.99
Basic Average Shares	$ 245.57M	$ 73.59M	$ 69.46M	$ 62.34M	$ 55.61M	$ 53.97M
Diluted Average Shares	$ 245.57M	$ 73.59M	$ 69.46M	$ 62.34M	$ 55.61M	$ 53.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 62.63M	$ 143.30M	$ -313.10M	$ 369.61M	$ 325.33M	$ 299.12M
Net Income From Continuing And Discontinued Operation	$ -63.99M	$ 872.13M	$ -261.49M	$ -278.02M	$ -236.46M	$ -215.52M
Normalized Income	$ -16.03M	$ -60.49M	-	$ -263.01M	$ -236.46M	$ -215.52M
Interest Expense	-	-	-	$ 44.59M	$ 31.86M	$ 10.48M
EBIT	$ -104.42M	$ -86.45M	$ -256.68M	$ -241.95M	$ -209.81M	$ -215.60M
EBITDA	$ -80.82M	$ -79.42M	$ -248.08M	$ -232.89M	$ -203.60M	$ -212.44M

Currency in USD

Theravance Biopharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing